DFMO and taxol for the treatment or prevention of breast cancer.

摘要

PREPARATIONS ARE DESCRIBED THAT INCLUDE A SINGLE ENANTIOM OR A DEFINED PROPORTION OF ALFADIFLUOROMETILORNITINE (DFMO) ENANTIOMERS, TO TREAT, PREVENT, AND CONTROL GROWTH AND / OR TO REDUCE THE RISK OF DEVELOPING CANCER OR INDEPENDENT STUMP. PREPARATIONS CONTAINING A DIFFERENT JUST OF DFMO OR A DEFINED NON-RACEMIC PROPORTION OF FANS OF DFMO WILL PROVIDE AN IMPROVED PHARMACOLOGICAL ACTIVITY IN RELATION TO A PREPARATION THAT INCLUDES RACEMIC DFMO. PROCEDURES TO TREAT A PATIENT WHO PRESENTS INDEPENDENT BREAST CANCER CANCER ARE ALSO DESCRIBED, INCLUDING SUCH PROCEDURES TO MANAGE DFMO ONLY OR COMBINED WITH TAXOL.